Analysts: Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

1.06USD
11 Jul 2014
Price Change (% chg)

-- (+0.00%)
Prev Close
$1.06
Open
$1.05
Day's High
$1.07
Day's Low
$1.04
Volume
340,088
Avg. Vol
267,293
52-wk High
$4.20
52-wk Low
$0.80

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.03 February 12 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Aug-14 1 0.25 0.25 0.25 --
Quarter Ending Nov-14 1 0.30 0.30 0.30 --
Year Ending Feb-14 2 0.64 0.80 0.47 --
Year Ending Feb-15 1 10.88 10.88 10.88 12.70
Year Ending Feb-16 1 59.54 59.54 59.54 61.50
Earnings (per share)
Quarter Ending Aug-14 1 -0.03 -0.03 -0.03 --
Quarter Ending Nov-14 1 -0.03 -0.03 -0.03 --
Year Ending Feb-14 2 -0.12 -0.09 -0.15 --
Year Ending Feb-15 2 -0.09 -0.06 -0.12 -0.09
Year Ending Feb-16 2 0.05 0.22 -0.11 0.33

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Feb-14 0.17 0.20 0.03 18.24
Earnings (per share)
Quarter Ending Feb-14 -0.03 -0.02 0.01 -33.33

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Aug-14 0.25 0.25 0.25 0.25 --
Quarter Ending Nov-14 0.30 0.30 0.30 0.30 --
Year Ending Feb-14 0.64 -- -- -- --
Year Ending Feb-15 10.88 10.88 10.88 10.88 12.70
Year Ending Feb-16 59.54 59.54 59.54 59.54 61.50
Earnings (per share)
Quarter Ending Aug-14 -0.03 -0.03 -0.03 -0.03 --
Quarter Ending Nov-14 -0.03 -0.03 -0.03 -0.03 --
Year Ending Feb-14 -0.12 -- -- -- --
Year Ending Feb-15 -0.09 -0.09 -0.09 -0.09 -0.09
Year Ending Feb-16 0.05 0.05 0.06 0.06 0.33

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Aug-14 0 0 0 0
Quarter Ending Nov-14 0 0 0 0
Year Ending Feb-14 -- -- -- --
Year Ending Feb-15 0 0 0 0
Year Ending Feb-16 0 0 0 0
Earnings
Quarter Ending Aug-14 0 0 0 0
Quarter Ending Nov-14 0 0 0 0
Year Ending Feb-14 -- -- -- --
Year Ending Feb-15 0 0 0 0
Year Ending Feb-16 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: TheStreet.com Ratings
$10.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks